http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112870183-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
filingDate | 2021-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2023-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2023-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-112870183-B |
titleOfInvention | A kind of anti-inflammatory drug and its application in preparation of anti-acute inflammation drug |
abstract | The invention belongs to the field of plant active substances, and in particular relates to an anti-inflammatory drug and its application in the preparation of anti-acute inflammation drugs. The anti-inflammatory drug should at least contain cotoside, and may also contain other anti-inflammatory drugs. The dosage form of the anti-inflammatory drug can be selected from oral tablet, oral granule, fat emulsion injection, cyclodextrin inclusion compound for injection and the like. The anti-inflammatory drug of the present invention has anti-inflammatory effect on acute inflammation induced by xylene, acute pneumonia induced by lipopolysaccharide, acute hepatitis induced by sepsis, etc., and is beneficial to improve tissue and organ damage caused by acute inflammation through anti-inflammatory effect . |
priorityDate | 2021-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 168.